Posters & Presentations
Molecular and cellular signatures accompanying early disease clearance in Ulcerative Colitis patients treated with vedolizumab in the VERDICT trial
Digital Oral Presentation DOP046
Session Information
Session: Genetics and Omics in IBD
Presenter: Dr. Nick Powell
Date: February 19, 2026
Time: 5:45–6:45 PM CET
Session Hall: A13
Pharmacokinetics and transcriptomic analysis reveal the molecular signature of mucosal healing in patients with Acute Severe Ulcerative Colitis treated with infliximab (PROTOS)
Digital Oral Presentation DOP066
Session Information
Session: Diagnostics, Biomarkers and Monitoring II
Presenter: Dr. Robert Battat
Date: February 20, 2026
Time: 8:30–9:30 AM CET
Session Hall: A7
Psychometric validation of the revised Symptoms and Impacts Questionnaire for Crohn’s Disease (SIQ-CD) and Ulcerative Colitis (SIQ-UC)
Guided Poster Session P1074
Session Information
Presenter: Dr. Marianne Hupé
Date: February 20, 2026
Time: 12:40–1:40 PM CET
Session Hall: Poster Exhibition, Hall A
Evaluation of transmural healing in patients with moderately to severely active Crohn’s disease shows early efficacy of vedolizumab: VECTORS week 14 interim analysis
Guided Poster Session P1007
Session Information
Presenter: Dr. Vipul Jairath
Date: February 20, 2026
Time: 12:40–1:40 PM CET
Session Hall: Poster Exhibition, Hall A
Schedule a Meeting
Fields marked with * are required.